John Timberlake Presents Berkshire Biomedical at LSI USA '23

Berkshire Biomedical Corporation is developing drug delivery devices by pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems to provide accurate personalized medication delivery to the authenticated Intended User.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
John Timberlake
John Timberlake
President & CEO, Berkshire Biomedical